Polynoma Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
Polynoma General Information
Description
Developer of an immuno-oncology vaccine focused on the treatment of melanoma. The company's oncology-focused biotechnology offers antigen vaccines which include a novel, polyvalent antigen vaccine, multicenter, double- blind seviprotimut-L.
Contact Information
Website
www.polynoma.comCorporate Office
- 11230 Sorrento Valley Road
- Suite 215
- San Diego, CA 92121
- United States
Corporate Office
- 11230 Sorrento Valley Road
- Suite 215
- San Diego, CA 92121
- United States
Polynoma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Polynoma Patents
Polynoma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2016168361-A1 | Polyvalent vaccines and combination therapy for the treatment of melanoma | Inactive | 14-Apr-2015 |
Polynoma Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Polynoma FAQs
-
When was Polynoma founded?
Polynoma was founded in 2007.
-
Where is Polynoma headquartered?
Polynoma is headquartered in San Diego, CA.
-
What industry is Polynoma in?
Polynoma’s primary industry is Drug Discovery.
-
Is Polynoma a private or public company?
Polynoma is a Private company.
-
What is Polynoma’s current revenue?
The current revenue for Polynoma is .
-
Who are Polynoma’s investors?
CK Life Sciences Int'l., (Holdings) has invested in Polynoma.
-
When was Polynoma acquired?
Polynoma was acquired on 08-Oct-2025.
-
Who acquired Polynoma?
Polynoma was acquired by TransCode Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process